CD7 is expressed on thymocytes, NK precursors, T-lymphocytes and in about 30% of AML cases, where its high expression level has been associated with more aggressive disease and resistance to conventional therapy [73]. This evidence concerns the gene CD7 and acute myeloid leukemia.